NCT05891106View on ClinicalTrials.gov

AONDA Therapeutic Indication Study I

CompletedOBSERVATIONAL
Enrollment

55

Participants

Timeline

Start Date

June 28, 2023

Primary Completion Date

July 10, 2023

Study Completion Date

July 10, 2023

Conditions
Bullous KeratopathyCorneal ErosionEntropionCorneal EdemaCorneal DystrophyCorneal UlcerForeign Body in CorneaBell PalsyKeratoconjunctivitisFilamentary KeratitisSicca Syndrome; Keratoconjunctivitis (Etiology)
Interventions
DEVICE

Lotrafilcon A contact lenses

CE-marked silicone hydrogel contact lenses

Trial Locations (3)

32803

Vision Health Institute, Orlando

38111

Optometry Group, PLLC, Memphis

60131

Franklin Park Eye Center PC, Franklin Park

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY